miR-204-5p acts as a tumor suppressor in laryngeal squamous cell carcinoma (LSCC) (Gao et al., 2017; Fan et al., 2023), targets anti-apoptotic protein BCL2 in prostate cancer (PCa) (Lin et al., 2017) and serves as an early diagnostic biomarker in endometrial cancer (EC) (Wu et al., 2022). Here, BCL2 is linked to prostate carcinoma.